BMJ Clinical Evidence is one of the world's most authoritative medical resources for informing treatment decisions and improving patient care.
Latest updated reviews
- Acute carbon monoxide poisoning (updated)
- Ocular herpes simplex (updated)
- Bronchitis (acute) (updated)
- Recurrent cystitis in non-pregnant women (updated)
- Community-acquired pneumonia (updated)
- Halitosis (updated)
- Inguinal hernia (updated)
- HIV: treating Pneumocystis pneumonia (PCP) (updated)
- Otitis externa (updated)
- Summary of all updates
Guest Editorial
In resource-rich countries, chronic paediatric illnesses are rare. But this low prevalence has contributed to the lack of an evidence base for children as comprehensive as that available for adults. It may be that, as discussed by Michael Silverstein and Howard Bauchner, considering children with chronic conditions separately from those without them could help to remedy this gap in the evidence.
Drug safety alerts
- EMEA issues drug safety alert on the increased risk of fibrosis, particularly cardiac fibrosis associated with chronic use of ergot-derived dopamine agonists.
(28 June 2008) - FDA issues drug safety alert on increased risk of cancer mortality associated with use of 3 or more tubes of becaplermin.
(09 June 2008) - Long term use of thiazolidinediones linked to increased fracture risk.
(29 April 2008)
Our methods
The systematic reviews in BMJ Clinical Evidence result from a rigorous process aimed at ensuring that they are both reliable and relevant to clinical practice.
Learn about our methods.
Consultancy reviews
Smoking cessation
We present a new review on an evidence-based approach to Smoking cessation.
Managing HIV infection
View our systematic reviews on the challenges of managing HIV/AIDS in resource-poor settings.
July 23, 2008
News Feeds & Email Alerts
Activate your subscription
Handbook & Online subscribers:
Activate your online account
Articles and Research section
Access the latest independent research on BMJ Clinical Evidence









